Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
- 24 November 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 40 (5) , 955-961
Abstract
Antibody detection is essential to establish exposure, infection, and immunity to SARS-CoV-2, as well as to perform epidemiological studies. The worldwide urge for new diagnostic tools to control the pandemic has led to a quick incorporation in clinical practice of the recently developed serological assays. However, as only few comparative studies have been published, there is a lack of data about the diagnostic accuracy of currently available assays. We evaluated the diagnostic accuracy to detect Ig G, Ig M+A, and/or IgA anti SARS-CoV-2 of 10 different assays: lateral flow card immunoassays, 4 enzyme-linked immunosorbent assay (ELISA), and 3 chemiluminescent particle immunoassays (CMIA). Using reverse transcriptase polymerase chain reaction (RT-PCR) for COVID-19 as gold standard, sensitivity, specificity, PPV, and NPV were determined. Each assay was tested in 2 groups, namely, positive control, formed by 50 sera from 50 patients with SARS-CoV-2 pneumonia with positive RT-PCR; and negative control, formed by 50 sera from 50 patients with respiratory infection non-COVID-19. Sensitivity range of the 10 assays evaluated for patients with positive COVID-19 RT-PCR was 40–77% (65–81% considering IgG plus IgM). Specificity ranged 83–100%. VPP and VPN were respectively 81–100% and 61.6–81%. Among the lateral flow immunoassays, the highest sensitivity and specificity results were found in Wondfo® SARS-CoV-2 Antibody Test. ELISA IgG and IgA from EUROIMMUN® were the most sensitive ELISA. However, poor results were obtained for isolated detection of IgG. We found similar sensitivity for IgG with SARS-CoV-2 for Architect by Abbott® and ELISA by Vircell®. Results obtained varied widely among the assays evaluated. Due to a better specificity, overall diagnostic accuracy of the assays evaluated was higher in case of positive result. On the other side, lack of antibody detection should be taken with care because of the low sensitivity described. Highest diagnostic accuracy was obtained with ELISA and CMIAs, but they last much longer.Keywords
This publication has 11 references indexed in Scilit:
- False Negative Tests for SARS-CoV-2 Infection — Challenges and ImplicationsNew England Journal of Medicine, 2020
- Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunitybioRxiv, 2020
- Test performance evaluation of SARS-CoV-2 serological assaysmedRxiv, 2020
- Evaluation of nine commercial SARS-CoV-2 immunoassaysmedRxiv, 2020
- Coronavirus disease 2019 (COVID-19): a clinical updateFrontiers of Medicine, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- SARS-CoV-2 and Coronavirus Disease 2019: What We Know So FarPathogens, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Confidence intervals for predictive values with an emphasis to case–control studiesStatistics in Medicine, 2007